BCR-ABL1, Quantitative, Major

Specimen Collection, Storage, and Shipping

Test Information:

The test uses reverse transcription and PCR to detect and quantify BCR-ABL1 fusion genes resulting from the t(9;22)(q34.12q11.23) (Philadelphia chromosome) translocation involving b2a2 and b3a2 major BCR (MBCR, p210) breakpoints. The t(9;22) is found in chronic myelogenous leukemias (CML) and a subset of acute lymphoblastic leukemia (ALL) patients (about 25% of adult and 5% of childhood ALLs). The test is designed to monitor patients with known CML for residual disease and reports patient results based on the International Scale. Patient results and log reductions are relative to the IRIS baseline. This test does not detect and quantify minor BCR (mBCR, p190), micro BCR BCR, p230) or other major BCR transcripts.

Requisition Code:

BCR-ABL1, Quantitative, Major

CPT Code:

81206; G0452-26

Turn Around Time:

10-14 days

Specimen Requirements:

Collect:           Peripheral blood: 2-5 mL in EDTA (purple top) tube

                        Bone marrow: 2-5 mL in ACD (yellow) or EDTA (purple) tube

Storage:         Refrigerate

Remarks:       Specimens must be received within 72 hours from collection due to instability of RNA. WBCC is required to accompany specimen.

Transport:      See Standard Shipping Procedure


Cross NCP et al., Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia (2015) 29, 999–1003.